Khosla Ventures
Listed as “Rubedo”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Rubedo
Rubedo discovers and develops medicines targeting cells associated with aging.
- Tracked VC backers
- 1
RiseFinder summary
Rubedo discovers and develops medicines targeting cells associated with aging. Its team describes experience in drug discovery and regenerative medicine. The company also lists medicinal chemistry, artificial intelligence and informatics among its areas of expertise. Rubedo says its work focuses on cells involved in the aging process.
- Company website ↗ · Checked
Tracking coverage and points
Tracking coverage
Some source history is available; coverage remains limited.
- Momentum +1 · Limited coverage
- The latest public index does not report a rank for this company.Index checked:
- Fundraising +2 · Awaiting data
- No verified dated source evidence recorded.
- New VC +3 · Awaiting data
- No verified dated source evidence recorded.
- Completed exit +10 · Awaiting data
- Exit news coverage has not started.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.